Tuberculosis Treatment

You treat tuberculosis with a combination of antibiotics, taken every day or on a set schedule, for months. WHO stated in 2026 that TB disease is treated with antibiotics and can be fatal without treatment. Plans mix and match six drugs: ethambutol, isoniazid, moxifloxacin, rifampin, rifapentine and pyrazinamide¹. Inactive TB needs only isoniazid, rifampin or rifapentine¹. In 2026, WHO named rifampicin, isoniazid, pyrazinamide and ethambutol as the most common, taken daily for about 4 to 6 months⁷. CDC guidance from 2025 sets four goals: cure, fewer deaths and disabilities, less spread, and no new drug resistance². Most of these drugs work best on an empty stomach, with rifapentine the exception².

Each of these drugs has its own dose, schedule and side effects. The guide to the drugs that treat TB takes them one at a time.

Tuberculosis treatment takes 4, 6 or 9 months for active TB disease. Inactive TB takes 3, 4, 6 or 9 months, depending on the regimen. Drug-resistant TB can take months or even years¹. The first, intensive phase usually lasts 2 months, killing the actively growing germs and easing the worst symptoms². The continuation phase then clears the germs left behind, lowering the chance of failure and relapse². Lab results at the end of the first phase guide choices for the second². For the wider course of the illness, see how long tuberculosis lasts.

The standard regimen for TB disease is RIPE: rifampin, isoniazid, pyrazinamide and ethambutol. It runs 6 months, with all four drugs for 2 months and then rifampin and isoniazid for 4.

CDC guidance from 2025 recommends the 6-month regimen for adults and adolescents². Each drug in the four-drug mix is explained under RIPE therapy. In 2025 guidance, the 9-month version covers people whose first phase lacked pyrazinamide, or with HIV but no HIV medicines².

CDC guidance from 2025 adds a 4-month regimen of rifapentine, moxifloxacin, isoniazid and pyrazinamide to the 6-month standard. It is for people 12 and older who weigh at least 40 kg and meet the other conditions. People with HIV qualify when their CD4 count is at least 100 and their HIV medicines are compatible². The regimen is meant for lung TB that is not known or suspected to be drug-resistant². It gives four drugs for 2 months, then isoniazid, rifapentine and moxifloxacin for 2 months and 1 week². The full set of tuberculosis treatment guidelines covers the other regimens.

Directly observed therapy, or DOT, means a health worker watches you take each dose of TB medicine. CDC guidance from 2025 calls DOT the standard of care and counts video DOT as its equal. A health worker meets you every day or several times a week, either in person or virtually³. In-person DOT can suit people who receive injections, need closer checks or cannot use video². Without DOT, CDC suggested in 2025 taking pills at the same time daily and setting alarms³. A pill box, a tracker or a reminder from someone helps too³. How sessions are set up is covered under directly observed therapy (DOT).

Inactive TB is treated with a shorter course of fewer drugs than active disease. CDC guidance from 2025 prefers 3HP, 4R or 3HR, which take 3 or 4 months. When a short regimen cannot be used, 6 or 9 months of isoniazid is the fallback⁴. 3HP means 12 weekly doses, while 4R is 120 daily doses and 3HR is 90 daily doses⁴. Finished treatment is 90% effective at preventing TB disease (CDC clinical overview, 2025). About 80% of US TB cases trace back to inactive TB that was never treated (CDC clinical overview, 2025). Testing and follow-up for latent tuberculosis are covered on their own page.

Drug-resistant TB is TB that the usual drugs no longer kill, so it is treated with other medicines. Treatment can take months or years and should be managed by or with a TB expert. WHO stated in 2026 that MDR-TB is treatable and curable, though its drugs cost more and cause more side effects⁷. MDR TB resists at least isoniazid and rifampin⁸. Under CDC guidance from 2025, BPaLM runs 6 months for people 14 and older with rifampin-resistant lung TB⁸. BPaLM combines bedaquiline, pretomanid, linezolid and moxifloxacin⁸. WHO reported in 2026 that about 34,000 people started 6-month MDR/RR-TB regimens in 2024, up from 5,653 in 2023⁷. Even so, WHO found in 2026 that only about 2 in 5 people with MDR-TB got treatment in 2024⁷. The forms of resistance are compared under drug-resistant TB.

Tuberculosis medicines cause minor side effects such as rash, upset stomach and nausea, which food helps ease. Serious effects such as liver injury, with belly pain or yellow eyes, need a call to your provider at once. Call your provider promptly about these signs too³.

• Dizziness or lightheadedness
• Loss of appetite
• Flu-like symptoms

People at risk of nerve damage take vitamin B6, 25 to 50 mg a day, alongside isoniazid². Rifampin and rifapentine tint urine, tears and sweat orange; this is harmless, but soft contact lenses can stain for good³. Ethambutol can inflame the optic nerve and dim eyesight, so eyes are tested before and during treatment (ethambutol label). Pyrazinamide raises uric acid and is stopped if gout develops (pyrazinamide label). CDC guidance from 2025 says to stop the medicine and seek care for dark urine, lasting numbness, vision changes or rash². The page on ethambutol vision changes explains the eye checks.

Doctors check TB treatment at visits at least once a month, with sputum tests, blood tests and chest X-rays as needed. Symptoms should ease gradually, and a lack of progress by 2 months prompts a closer look. If symptoms do not improve in 2 months, or return, doctors look for missed doses, poor absorption or drug resistance². A chest X-ray comes before treatment, and again at 2 months if early cultures were negative². People with HIV or diabetes may need tests before and after treatment³. Keep every appointment and ask for a written record of finished treatment, since TB tests can stay positive³.

Yes, at first; CDC guidance from 2025 says most patients may no longer be infectious after a few weeks of medicine. A provider uses repeat sputum tests or chest X-rays to judge when work or school is safe again. Until then, sleep in a separate room and let fresh air into your room (CDC Prevention, 2025). In the hospital, patients stay in a special room whose air does not flow to other rooms (CDC Prevention, 2025). Hospitals end airborne precautions after 3 consecutive negative sputum smears on separate days in an improving patient on effective therapy (CDC, 2026). Only TB of the lungs or throat usually spreads, and TB elsewhere in the body usually does not (CDC Causes, 2025). Close contacts are covered on the page about how tuberculosis spreads.

Stopping TB treatment early lets surviving germs make you sick again and turn resistant to the drugs. You will probably feel well within a few weeks, but feeling well does not mean the germs are gone. CDC guidance from 2025 is plain: do not miss doses, and do not stop early¹. WHO called stopping early or without medical advice dangerous in 2026, because it can breed resistance⁷. If you miss a dose, skip it, take the next one when it is due and let your provider know³. Tell your provider about any trouble taking the medicine, or needs such as food, clean water or transport³.

TB is hard to treat because some germs outlive the first weeks of medicine, and clearing them takes months. One drug alone is not enough, since a few resistant germs can quickly outgrow the rest. The rifampin label states that resistance arises from single-step mutations in the germ. CDC guidance from 2025 says several medicines together kill more germs and help prevent resistance³. Missed doses raise the risk of drug resistance⁵.

Yes, children aged 3 months to 16 years with non-severe TB disease have a 4-month option in place of 6. CDC guidance from 2025 advises a pediatric TB expert before any child starts treatment. Non-severe means TB of lymph nodes outside the chest, chest lymph nodes without airway blockage, or uncomplicated fluid around the lung⁶. Other children take 2 months of four drugs, then 4 months of isoniazid and rifampin⁶. Children 12 and older who weigh at least 40 kg may take the 4-month rifapentine-moxifloxacin regimen⁶. All children and adolescents with TB disease should get DOT⁶. Children under 5 face a higher risk of disease after infection, and miliary TB is more common at that age⁵. Testing and symptoms are covered under tuberculosis in children.

TB outside the lungs is treated with TB medicines too, and the site of disease affects the regimen and its length. CDC guidance from 2025 advises consulting a TB expert for these cases. TB can affect the larynx, lymph nodes, pleura, brain, kidneys, and bones and joints, though most cases are in the lungs⁵. In children, the 6-month four-drug regimen treats most TB outside the lungs⁶. Disseminated TB and TB meningitis in children need 9 to 12 months⁶. Steroids may be needed for a few weeks if TB reaches the brain, spinal cord or heart lining (NHS, 2026). Miliary TB is fatal if untreated⁵. Infection of the brain lining has its own page on tuberculous meningitis of the brain.

Yes, TB can be cured with treatment, and WHO stated in 2026 that TB is preventable and curable. Active TB is cured with 4, 6 or 9 months of antibiotics, depending on the regimen. WHO estimated in 2026 that TB and HIV treatment have averted 9.8 million deaths since 2005⁷. CDC guidance from 2025 says full treatment with a fitting regimen cures almost all patients². The question is tuberculosis curable gets a full answer on its own page.

These short answers cover natural remedies, history, alcohol and getting TB again.